Waltham, MA, United States of America

Richard Donald Woessner


 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Richard Donald Woessner: Innovator in JAK Inhibition

Introduction

Richard Donald Woessner, based in Waltham, MA, is a notable inventor with a strong focus on pharmaceutical innovations. With a total of three patents to his name, he has made significant contributions to the field of medicine, particularly in the treatment of JAK-related disorders.

Latest Patents

Among his latest innovations, Woessner has developed compounds and methods for inhibiting JAK. These patents describe compounds of formula (I), pharmaceutical compositions comprising such compounds, and methods for utilizing them in treating JAK-related disorders such as cancer, cancer cachexia, or various immune disorders. His work represents a vital advancement in the medical field, providing new avenues for treatment.

Career Highlights

Richard currently works for Dizal Pharmaceutical Co., Ltd., where he leverages his expertise to further develop pharmaceutical solutions. His involvement in this innovative company reflects his dedication to improving healthcare through scientific development.

Collaborations

Throughout his career, Woessner has collaborated with talented professionals such as Neil Patrick Grimster and Sameer Pralhad Kawatkar. These partnerships have likely enriched his research experience and contributed to the success of his inventions.

Conclusion

Richard Donald Woessner stands out as a prominent inventor in the field of pharmaceutical innovation. His patents focusing on JAK inhibition highlight his commitment to addressing significant health challenges. With ongoing collaborations and a solid career foundation, Woessner's contributions to medicine will undoubtedly have a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…